Profilo
Chuck Yon was the founder of Checkmate Pharmaceuticals, Inc. founded in 2015, where he held the title of General Counsel from 2015 to 2021.
Mr. Yon's former jobs include Secretary, Senior Vice President & General Counsel at Coley Pharmaceutical Group, Inc. from 2001 to 2008, and Senior Vice President & General Counsel at Astra Pharmaceutical Products, Inc. from 1989 to 1999.
Mr. Yon's education history includes a graduate degree from Georgetown University Law Center, an MBA from Kellogg School of Management, and a graduate degree from Harvard College.
Precedenti posizioni note di Chuck Yon
| Società | Posizione | Fine |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Fondatore | 04/01/2021 |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Consigliere Generale | 01/01/2008 |
Astra Pharmaceutical Products, Inc. | Consigliere Generale | 01/01/1999 |
Formazione di Chuck Yon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Health Technology |
Astra Pharmaceutical Products, Inc. | |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
















